266 related articles for article (PubMed ID: 23244675)
1. Robustness of IMPT treatment plans with respect to inter-fractional set-up uncertainties: impact of various beam arrangements for cranial targets.
Hopfgartner J; Stock M; Knäusl B; Georg D
Acta Oncol; 2013 Apr; 52(3):570-9. PubMed ID: 23244675
[TBL] [Abstract][Full Text] [Related]
2. Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors.
Kraan AC; van de Water S; Teguh DN; Al-Mamgani A; Madden T; Kooy HM; Heijmen BJ; Hoogeman MS
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):888-96. PubMed ID: 24351409
[TBL] [Abstract][Full Text] [Related]
3. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
[TBL] [Abstract][Full Text] [Related]
4. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets.
Thörnqvist S; Muren LP; Bentzen L; Hysing LB; Høyer M; Grau C; Petersen JB
Acta Oncol; 2013 Apr; 52(3):521-7. PubMed ID: 23409771
[TBL] [Abstract][Full Text] [Related]
5. Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer.
Stefanowicz S; Stützer K; Zschaeck S; Jakobi A; Troost EGC
Radiat Oncol; 2018 Nov; 13(1):228. PubMed ID: 30466468
[TBL] [Abstract][Full Text] [Related]
6. A method for evaluation of proton plan robustness towards inter-fractional motion applied to pelvic lymph node irradiation.
Andersen AG; Casares-Magaz O; Muren LP; Toftegaard J; Bentzen L; Thörnqvist S; Petersen JB
Acta Oncol; 2015; 54(9):1643-50. PubMed ID: 26203931
[TBL] [Abstract][Full Text] [Related]
7. ART for head and neck patients: On the difference between VMAT and IMPT.
Góra J; Kuess P; Stock M; Andrzejewski P; Knäusl B; Paskeviciute B; Altorjai G; Georg D
Acta Oncol; 2015; 54(8):1166-74. PubMed ID: 25850583
[TBL] [Abstract][Full Text] [Related]
8. Advantages and limitations of the 'worst case scenario' approach in IMPT treatment planning.
Casiraghi M; Albertini F; Lomax AJ
Phys Med Biol; 2013 Mar; 58(5):1323-39. PubMed ID: 23391569
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of localization errors for craniospinal axis irradiation delivery using volume modulated arc therapy and proposal of a technique to minimize such errors.
Myers P; Stathakis S; Mavroidis P; Esquivel C; Papanikolaou N
Radiother Oncol; 2013 Jul; 108(1):107-13. PubMed ID: 23791305
[TBL] [Abstract][Full Text] [Related]
10. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
Stützer K; Lin A; Kirk M; Lin L
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
[TBL] [Abstract][Full Text] [Related]
11. Effect of intrafraction prostate motion on proton pencil beam scanning delivery: a quantitative assessment.
Tang S; Deville C; McDonough J; Tochner Z; Wang KK; Vapiwala N; Both S
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):375-82. PubMed ID: 23958148
[TBL] [Abstract][Full Text] [Related]
12. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.
Liu W; Schild SE; Chang JY; Liao Z; Chang YH; Wen Z; Shen J; Stoker JB; Ding X; Hu Y; Sahoo N; Herman MG; Vargas C; Keole S; Wong W; Bues M
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):523-533. PubMed ID: 26725727
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
[TBL] [Abstract][Full Text] [Related]
14. Intensity modulated proton therapy for craniospinal irradiation: organ-at-risk exposure and a low-gradient junctioning technique.
Stoker JB; Grant J; Zhu XR; Pidikiti R; Mahajan A; Grosshans DR
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):637-44. PubMed ID: 25194667
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric robustness against setup errors in charged particle radiotherapy of skull base tumors.
Ammazzalorso F; Jelen U; Engenhart-Cabillic R; Schlegel W
Radiat Oncol; 2014 Dec; 9():279. PubMed ID: 25477197
[TBL] [Abstract][Full Text] [Related]
16. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
Weber DC; Trofimov AV; Delaney TF; Bortfeld T
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
[TBL] [Abstract][Full Text] [Related]
17. Robust treatment planning with conditional value at risk chance constraints in intensity-modulated proton therapy.
An Y; Liang J; Schild SE; Bues M; Liu W
Med Phys; 2017 Jan; 44(1):28-36. PubMed ID: 28044325
[TBL] [Abstract][Full Text] [Related]
18. Comparing proton treatment plans of pediatric brain tumors in two pencil beam scanning nozzles with different spot sizes.
Kralik JC; Xi L; Solberg TD; Simone CB; Lin L
J Appl Clin Med Phys; 2015 Nov; 16(6):41-50. PubMed ID: 26699553
[TBL] [Abstract][Full Text] [Related]
19. Integrated beam orientation and scanning-spot optimization in intensity-modulated proton therapy for brain and unilateral head and neck tumors.
Gu W; O'Connor D; Nguyen D; Yu VY; Ruan D; Dong L; Sheng K
Med Phys; 2018 Apr; 45(4):1338-1350. PubMed ID: 29394454
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric benefits of robust treatment planning for intensity modulated proton therapy for base-of-skull cancers.
Liu W; Mohan R; Park P; Liu Z; Li H; Li X; Li Y; Wu R; Sahoo N; Dong L; Zhu XR; Grosshans DR
Pract Radiat Oncol; 2014; 4(6):384-91. PubMed ID: 25407859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
